Advertisement

Related Videos

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

David A. Hyman, MD, JD, on Inclusive Shared Savings

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Dec
22
Today In Oncology
Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma
Study Finds Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders
MRI First Strategy May Be Safe for Prostate Cancer Detection
Addition of SBRT to Systemic Therapy May Improve Outcomes in Select Patients With Locally Advanced Hepatocellular Carcinoma
Epcoritamab Monotherapy for Pretreated Relapsed or Refractory CLL
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Conexiant Oncology Logo